Stage III Colon Cancer
Information
- Disease name
- Stage III Colon Cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04164069 | Active, not recruiting | Phase 1 | Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab | September 2, 2020 | December 31, 2023 |
| NCT03255434 | Active, not recruiting | Phase 2 | LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy | November 1, 2017 | December 2024 |
| NCT00004931 | Completed | Phase 3 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | February 2000 | |
| NCT00005818 | Completed | Phase 1/Phase 2 | SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer | March 2000 | |
| NCT00019006 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer | March 1995 | |
| NCT00025337 | Completed | Phase 3 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | September 2001 | |
| NCT00028496 | Completed | Phase 1 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | November 2001 | |
| NCT00003835 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | May 1999 | |
| NCT00079274 | Completed | Phase 3 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | February 2004 | November 2012 |
| NCT00089362 | Completed | Phase 1 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | July 2004 | |
| NCT00101348 | Completed | Phase 1/Phase 2 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | January 2005 | May 2008 |
| NCT00134069 | Completed | Phase 1 | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | June 2005 | December 2011 |
| NCT00138177 | Completed | Phase 1 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | July 2005 | |
| NCT00433576 | Completed | Phase 1 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | December 2006 | March 2009 |
| NCT00551421 | Completed | Phase 1/Phase 2 | Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | October 2007 | June 2012 |
| NCT01126346 | Completed | N/A | Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | May 2010 | October 2013 |
| NCT01158274 | Completed | Phase 1 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | June 2010 | |
| NCT01191684 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer | October 2011 | August 2013 |
| NCT01890213 | Completed | Phase 1 | Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | November 2013 | July 2019 |
| NCT02250053 | Completed | N/A | Exercise and Colon Cancer | December 2015 | January 15, 2016 |
| NCT02129218 | Completed | N/A | Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer | February 16, 2015 | July 10, 2018 |
| NCT00004074 | Completed | Phase 1 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | August 1999 | |
| NCT06287814 | Not yet recruiting | French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC) | March 1, 2024 | October 31, 2028 | |
| NCT05870800 | Not yet recruiting | Phase 2 | Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer | September 1, 2024 | January 1, 2028 |
| NCT04416490 | Recruiting | Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer | March 25, 2020 | March 31, 2026 | |
| NCT05062889 | Recruiting | Phase 2 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | May 17, 2023 | December 2027 |
| NCT05174169 | Recruiting | Phase 2/Phase 3 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | March 10, 2022 | March 10, 2030 |
| NCT03803553 | Recruiting | Phase 3 | Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer | April 16, 2020 | December 2027 |
| NCT00087191 | Terminated | N/A | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | May 2004 | |
| NCT03827044 | Terminated | Phase 3 | Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer | August 31, 2018 | January 5, 2022 |
| NCT01606124 | Terminated | Phase 2 | Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer | June 2012 | May 21, 2015 |
| NCT04044430 | Terminated | Phase 1 | Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer | August 31, 2020 | July 31, 2022 |
| NCT00070122 | Terminated | Phase 3 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | April 2004 | |
| NCT02280278 | Unknown status | Phase 3 | Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy | October 2014 | |
| NCT03154190 | Unknown status | N/A | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | August 8, 2017 | August 30, 2022 |
| NCT03422601 | Unknown status | Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment | July 13, 2017 | July 15, 2019 | |
| NCT03958435 | Unknown status | Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery | November 9, 2018 | December 15, 2023 | |
| NCT02836977 | Unknown status | N/A | Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection | March 2016 | February 29, 2024 |